Pharvaris (PHVS) Change in Accured Expenses (2020 - 2026)

Pharvaris (PHVS) has 7 years of Change in Accured Expenses data on file, last reported at -$5.1 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 812.72% year-over-year to -$5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (down 10.39% YoY) and the FY2025 annual result came in at $7.0 million, up 47.7% from the prior year.
• Change in Accured Expenses declined to -$5.1 million in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1033.0 billion in Q3 2023 to a low of -$1033.3 billion in Q2 2023.
• A 5-year average of -$17.9 million and a median of $1.2 million in 2022 frame the typical range for Change in Accured Expenses.
• The widest YoY moves for Change in Accured Expenses: up 86970295.74% in 2023, down 36593338.77% in 2023.
• Tracing PHVS's Change in Accured Expenses over 5 years: stood at $894776.3 in 2022, then sank by 212.17% to -$1.0 million in 2023, then jumped by 607.72% to $5.1 million in 2024, then slumped by 73.81% to $1.3 million in 2025, then slumped by 483.42% to -$5.1 million in 2026.
• The last three Change in Accured Expenses figures came in at -$5.1 million (Q1 2026), $1.3 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.